These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 33244794)
1. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma. Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1. Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078 [TBL] [Abstract][Full Text] [Related]
3. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
4. Recombinant canstatin inhibits the progression of hepatocellular carcinoma by repressing the HIF-1α/VEGF signaling pathway. Zhu L; Ao L; Guo Z; Yang Y; Wang Z; Gu Z; Xin Y; Zhou L; Zhang L Biomed Pharmacother; 2024 Oct; 179():117423. PubMed ID: 39260328 [TBL] [Abstract][Full Text] [Related]
5. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma. Wu Q; Chen X; Wang P; Wu Q; Qi X; Han X; Chen L; Meng X; Xu K ACS Appl Mater Interfaces; 2020 Feb; 12(7):8016-8029. PubMed ID: 31997633 [TBL] [Abstract][Full Text] [Related]
6. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Jiang H; Ma Y; Chen X; Pan S; Sun B; Krissansen GW; Sun X Cancer Sci; 2010 Apr; 101(4):975-83. PubMed ID: 20219070 [TBL] [Abstract][Full Text] [Related]
7. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status. Du S; Liu K; Gao P; Li Z; Zheng J Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648 [TBL] [Abstract][Full Text] [Related]
8. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Zhang X; Hu B; Sun YF; Huang XW; Cheng JW; Huang A; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J; Yang XR Clin Transl Med; 2021 Feb; 11(2):e335. PubMed ID: 33634982 [TBL] [Abstract][Full Text] [Related]
10. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo. Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2. Dong S; Li Z; Kong J; Wu S; Gao J; Sun W Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex. Wang HY; Zhang B; Zhou JN; Wang DX; Xu YC; Zeng Q; Jia YL; Xi JF; Nan X; He LJ; Yue W; Pei XT Cell Death Dis; 2019 Jun; 10(6):453. PubMed ID: 31186405 [TBL] [Abstract][Full Text] [Related]
13. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer. Chaudhary A; Bhardwaj SK; Khan A; Srivastava A; Sinha KK; Ali M; Haque R Biol Trace Elem Res; 2023 Jul; 201(7):3300-3310. PubMed ID: 36192614 [TBL] [Abstract][Full Text] [Related]
14. [Effects of arsenic trioxide on migration, invasion and apoptosis of hepatocellular carcinoma HepG2 cells]. He J; Xu B; Gao W; Su G; Yu H; Shen Y; Liu X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Feb; 37(1):105-111. PubMed ID: 32096383 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo. Zhao XS; Song PL; Sun B; Jiang HC; Liu TF Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495 [TBL] [Abstract][Full Text] [Related]
16. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167 [TBL] [Abstract][Full Text] [Related]
17. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression. Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201 [TBL] [Abstract][Full Text] [Related]
18. Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy. Huang Y; Xu Z; Wei Y; Han S; Cai X; Chen D AAPS PharmSciTech; 2022 Apr; 23(4):111. PubMed ID: 35411416 [TBL] [Abstract][Full Text] [Related]
19. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death. Park HK; Han BR; Park WH Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro. Wang GZ; Zhang W; Fang ZT; Zhang W; Yang MJ; Yang GW; Li S; Zhu L; Wang LL; Zhang WS; Liu R; Qian S; Wang JH; Qu XD J Cancer Res Clin Oncol; 2014 Jul; 140(7):1125-36. PubMed ID: 24756364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]